Transforming Human Health: Activating brain and muscle tissue to self-repair
Research team’s ongoing work on using stem cells to encourage brain and muscle to self-repair has celebrated successes
Research team’s ongoing work on using stem cells to encourage brain and muscle to self-repair has celebrated successes
An interdisciplinary team of scientists, funded by Medicine by Design, aims to use retinal stem cells to restore vision.
Scientists can now select individual cells from their local environment & study their molecular contents. The new tool will enable a deeper study of stem cells and other rare cell types for diagnostics & therapy.
Medicine by Design-funded research team says the new treatment approach is not far from clinical trials. This is one of the ways Medicine by Design is transforming human health.
Seven funded projects poised to impact many diseases including cystic fibrosis, ALS and vision loss.
Research to impact cancer, Alzheimer’s disease, autism, aneurysm and more.
Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.
'We think we can really accelerate the field and its capacity to improve lives'
Projects to advance stem cell and gene therapy, enhance understanding of how the body repairs itself, and generate new technologies that will propel the field for decades
Awards support high-calibre post-doctoral fellows at the University of Toronto and affiliated hospitals who have outstanding potential to become independent researchers in regenerative medicine
Nine funded projects span synthetic biology, computational modelling, immunoengineering and organoids
Cindi Morshead and Maryam Faiz talk about the work they presented at the annual meeting of the Society for Neuroscience.
Finding inspiration from an unlikely source, a team led by Andras Nagy at Sinai Health System has an answer for one of the most pressing questions in cell therapy: how to ensure its safety
Researchers seek to overcome lingering challenges and clear the way for improvements in management of the disease